Update shared on18 Sep 2025
Fair value Increased 5.18%The consensus price target for Sila Realty Trust has increased, primarily driven by improved revenue growth forecasts, with fair value rising from $28.17 to $29.62.
What's in the News
- Acquired two newly constructed inpatient rehabilitation facilities in Plano, Texas and Peoria, Arizona for $70.3 million, leased to Reunion Rehabilitation Hospitals and managed in partnership with Nobis Rehabilitation Partners.
- Acquired two medical outpatient buildings in Southlake, Texas for $16.15 million, leased to GI Alliance and a joint venture involving Baylor Scott & White Health.
- Filed a $250 million at-the-market common stock equity offering.
- Authorized a share repurchase program of up to $75 million over three years, with a $25 million annual cap; completed the initial buyback tranche, repurchasing 304,878 shares for $7.34 million.
- Added to multiple Russell indices, including the Russell 2000, 2500, and 3000, as well as associated value, small cap, and defensive benchmarks.
Valuation Changes
Summary of Valuation Changes for Sila Realty Trust
- The Consensus Analyst Price Target has risen from $28.17 to $29.62.
- The Consensus Revenue Growth forecasts for Sila Realty Trust has risen from 8.7% per annum to 9.5% per annum.
- The Future P/E for Sila Realty Trust remained effectively unchanged, moving only marginally from 35.34x to 35.85x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.